证券代码：300741 证券简称：华宝股份 编号：2019-004 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------|-------------------------|--------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 | 财通证券 | 赵新裕、莫凯文，华富基金 许一 | | 及人员姓名 | | | | 时间 | 2019 年 5 月 15 | 日下午 14:00-15:30 | | 地点 | 公司会议室 | | | 上市公司接待 | 副总裁、董事会秘书 | 胡伟 | | 人员姓名 | | | | 投资者关系活 | 1 | 、公司募投项目的进度：江西鹰潭华宝基地的投产时间？大致 | | 动主要内容介 绍 | | 的产能释放进度？销量是否跟得上？ | | | ...

证券代码：300741 证券简称：华宝股份 编号：2019-003 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------|-------------------------|--------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 | 东兴证券 | 娄倩，宁波银行 李春燕、唐文敏，荣腾投资 赵堃，银 | | 及人员姓名 | 叶投资 秦怀宝 | | | 时间 | 2019 年 4 月 23 | 日下午 14:30-16:30 | | 地点 | 公司会议室 | | | 上市公司接待 | | | | 人员姓名 | 副总裁、董事会秘书 | 胡伟 | | 投资者关系活 | 1 | 、公司此次分红是基于什么考虑？ | | 动主要内容介 绍 | 答：公司 2018 | 年度除募投项 ...

编号：2019-006 证券代码：300741 证券简称：华宝股份 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------|-----------------------------|--------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 | 西部证券 | 金文曦，交银施罗德 刘鹏、封晴 | | 及人员姓名 | | | | 时间 | 2019 年 6 月 5 日 | 上午 10:00-11:30 | | 地点 | 公司会议室 | | | 上市公司接待 | 副总裁、董事会秘书 | 胡伟 | | 人员姓名 | | | | 投资者关系活 | 1 | 、相比于在传统卷烟产品中的用量，烟用香精在爆珠烟中的用 | | 动主要内容介 绍 | 量情况？ | | | | | 答：爆珠烟 ...

证券代码：300741 证券简称：华宝股份 编号：2019-002 华宝香精股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------|----------------------------------------|----------------------------------------------------------| | | √ 特定对象调研 | 分析师会议 | | 投资者关系活 | □ 媒体采访 | 业绩说明会 | | 动类别 | □ 新闻发布会 | 路演活动 | | | □ 现场参观 | | | 参与单位名称 | 西部证券 金文曦，交银基金 | 封晴，景林资产 王雄、张炀民，富 | | 及人员姓名 | 恩德资产 吴金宫、钟杵 | | | 时间 | 2019 年 4 月 9 日下午 | 14:00-17:00 | | 地点 | 公司会议室 | | | 上市公司接待 | | | | 人员姓名 | 副总裁、董事会秘书 | | | 投资者关系活 | 1 、请介绍一下江西鹰潭的募投项目定位？ | | | 动主要内容介 绍 | | 答：华宝鹰潭食 ...

编号：2019-005 证券代码：300741 证券简称：华宝股份 | --- | --- | --- | |-----------------|-------------------------|--------------------------------------------------------| | | √ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 | | | | 及人员姓名 | 中信证券 | 薛缘、顾训丁、涂洋，富恩德基金 钟杵 | | 时间 | 2019 年 5 月 21 | 日上午 10:00-11:30 | | 地点 | 公司会议室 | | | 上市公司接待 | 副总裁、董事会秘书 | 胡伟 | | 人员姓名 | | | | 投资者关系活 | 1 | 、公司今年高比例分红的考虑？ | | 动主要内容介 绍 | | 答：公司历来重视股东的投资回报，本次分红是基于对公司未 | | | | 来发展前景的预期和信心，与广大投资者 ...

1 证券代码：300741 证券简称：华宝股份 华宝香精股份有限公司 投资者关系活动记录表 编号：2021-002 | --- | --- | --- | |-------------------------|---------------------------------------------------------|------------------------------------------------------------| | | □ 特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | √ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 及人员姓名 | 参与公司 2020 | 年度网上业绩说明会的投资者 | | 时间 | 2021 年 3 月 25 日 | 下午 15:00-17:00 | | 地点 | 约调研网络平台 | | | | 董事、总裁：袁肖琴女士 | | | 上市公司接待 | 独立董事：章焰生先生 | | | 人员姓名 | 副总裁、董事会秘书：胡伟先生 副总裁、财务总监： ...

1 证券代码：300741 证券简称：华宝股份 华宝香精股份有限公司 投资者关系活动记录表 编号：2021-001 | --- | --- | --- | |-------------------------|-------------------------------------|-----------------------------------------------------------------------------------------------------------------| | | √特定对象调研 | □ 分析师会议 | | 投资者关系活 | □ 媒体采访 | □ 业绩说明会 | | 动类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 其他 | | 参与单位名称 及人员姓名 | 中信建投证券 | 菅成广；中国人寿 麻锦涛、王礼彬 | | 时间 | 2021 年 3 月 23 日 上午 | 10:30-12:00 | | 地点 | 公司会议室 | | | 上市公司接待 人员姓名 | 副总裁、董事会秘书 | 胡伟 | | | | 胡伟先生首先介绍了公 ...

证券代码：300741 证券简称：华宝股份 华宝香精股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------------|--------------------------------------------------------|-------------|-------------|-------|-------|-------|-------|----------------------------------------------------------|-------|-------| | | | | | | | | | | | | | 投资者关系活动 | □特定对象调研 | □分析师会议 | | | | | | | | | | 类别 | □媒体采访 | □业绩说明会 | | | | | | | | | | | □新闻发布会 | □路演活动 | | | | | | | | | | | □现场参观 | | | | | | | | | | ...

Financial Performance - Revenue for Q3 2022 was CNY 464,206,780, an increase of 3.86% year-over-year[7] - Net profit attributable to shareholders decreased by 39.46% to CNY 135,474,933 in Q3 2022[7] - Net profit excluding non-recurring items was CNY 140,082,123, down 30.32% compared to the same period last year[7] - Basic earnings per share for Q3 2022 was CNY 0.22, a decline of 38.89% compared to the previous year[7] - Total operating revenue for the third quarter of 2022 was 1,366,434,332, slightly up from 1,363,646,670 in the same period last year, representing a growth of approximately 0.13%[33] - Net profit for the third quarter was 544,457,547, down from 769,971,505 in the previous year, indicating a decline of approximately 29.3%[36] - Total comprehensive income for the period was 589,408,061, a decrease from 762,329,124 in the previous period, representing a decline of approximately 22.7%[39] - Basic and diluted earnings per share decreased to 0.87 from 1.22, reflecting a decline of 28.7%[39] Cash Flow and Investments - Cash flow from operating activities for the year-to-date period was CNY 412,822,421, a decrease of 49.29% year-over-year[7] - Net cash flow from operating activities was 412,822,421, down from 814,118,717, indicating a decrease of 49.3%[43] - Cash inflow from investment activities significantly increased to 11,463,479,008 from 4,231,165,304, marking an increase of 171.5%[43] - Net cash flow from investment activities improved to 1,062,196,900 from a negative 1,243,689,630, showing a turnaround[43] - Cash received from investment recoveries increased by 173.18% to CNY 1,137,800,000, primarily due to the maturity of structured deposits[16] - The company reported a significant increase in cash received from investment recoveries, totaling 11,378,000,000 compared to 4,165,040,000 in the previous period, an increase of 173.5%[43] Assets and Liabilities - Total assets at the end of Q3 2022 were CNY 8,765,853,226, reflecting a 4.45% increase from the end of the previous year[7] - The company's total assets as of September 30, 2022, reached 8,765,853,226, compared to 8,392,050,769 at the beginning of the year, reflecting an increase of about 4.5%[32] - Current liabilities surged to 1,071,987,611 from 532,664,379, showing a significant increase of approximately 101.1%[32] - Long-term liabilities totaled 28,845,167, up from 19,569,117, representing an increase of about 47.5%[32] - Shareholders' equity attributable to the parent company decreased by 4.22% to CNY 7,381,770,002[7] - The total equity attributable to shareholders decreased to 7,381,770,002 from 7,707,268,109, a decline of about 4.2%[32] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,694[17] - The largest shareholder, Huafeng International Investment Holdings (China) Co., Ltd., holds 81.10% of shares, totaling 499,500,000 shares[17] - The second-largest shareholder, Shanghai Junhe Licheng Investment Management Center (Limited Partnership), holds 3.41% of shares, totaling 20,971,800 shares[17] Operational Changes and Investigations - The company is under investigation for legal issues involving its actual controller and a board member, which may impact future operations[24] - The company has not disclosed any new product developments or market expansion strategies in the current report[24] - The company will continue to fulfill its information disclosure obligations as per regulations regarding the ongoing investigations[24] Inventory and Other Assets - The company's inventory as of September 30, 2022, is CNY 491,453,802, compared to CNY 426,517,884 at the beginning of the year[26] - The company's accounts receivable increased to CNY 591,929,984 from CNY 462,203,052 at the beginning of the year[26] - The company reported other current assets of CNY 65,462,176, up from CNY 54,771,069 at the beginning of the year[26] Research and Development - Research and development expenses for the quarter were 107,043,098, compared to 100,015,648 in the previous year, indicating an increase of about 7%[33] Tax and Audit - Total tax payments were 310,099,278, slightly up from 308,003,814, indicating a marginal increase of 0.7%[43] - The company did not undergo an audit for the third quarter report[44]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥902,227,552, a decrease of 1.58% compared to ¥916,678,395 in the same period last year[27]. - The net profit attributable to shareholders for the first half of 2022 was ¥399,042,619, down 24.68% from ¥529,772,568 in the previous year[27]. - The net profit after deducting non-recurring gains and losses was ¥299,722,636, a decline of 29.42% compared to ¥424,647,419 in the same period last year[27]. - The net cash flow from operating activities was ¥228,956,600, a significant drop of 55.12% from ¥510,102,908 in the previous year[27]. - Basic earnings per share for the first half of 2022 were ¥0.65, down 24.42% from ¥0.86 in the same period last year[27]. - Total assets at the end of the reporting period were ¥8,249,815,131, a decrease of 1.69% from ¥8,392,050,769 at the end of the previous year[27]. - The net assets attributable to shareholders at the end of the reporting period were ¥7,220,211,254, down 6.32% from ¥7,707,268,109 at the end of the previous year[27]. - The weighted average return on net assets was 5.26%, a decrease of 1.66% compared to 6.92% in the previous year[27]. Operational Strategy - The company operates 44 subsidiaries domestically and internationally, indicating a significant scale of operations[42]. - The company focuses on R&D, production, and sales of flavoring agents and food ingredients, with major products including food flavors and daily-use flavors[39]. - The company employs a direct control model for wholly-owned subsidiaries, ensuring effective management and governance[42]. - The production model combines planned production with "production based on sales," allowing for flexibility in meeting customer demands[44]. - The company has established a comprehensive procurement management system, centralizing procurement for subsidiaries with sales exceeding ¥100 million[43]. - The company emphasizes innovation and customer value, aiming to provide systematic solutions and comprehensive technical services[39]. Market Trends and Innovations - The flavoring industry is expected to continue growing, driven by the expansion of downstream industries such as food and daily chemicals[46]. - The company is focusing on product innovation and upgrading in the food ingredient sector, collaborating with major clients like Orion and Mondelēz[58]. - The company is actively expanding its overseas research, production, and sales networks, particularly in Singapore, Malaysia, and Indonesia[55]. - The company is investing in the development of new tobacco flavors, responding to regulatory changes and market opportunities in the new tobacco sector[55]. - The company is advancing its research in natural plant extracts, particularly in relation to new tobacco regulations[60]. - The company is implementing a strategic shift from "selling flavor products" to "providing solutions" in its business model[53]. - The company is committed to technological innovation and product development, focusing on clean production and sustainable practices[54]. Financial Management and Investments - The total investment amount for the reporting period reached ¥6,043,257,389, representing a 117.68% increase compared to ¥2,776,151,976 in the same period last year[96]. - The company acquired a 67.24% stake in Shanghai Yifang Agricultural Technology Co., Ltd. for ¥121,500,000, making it a subsidiary included in the consolidated financial statements[96]. - The fair value change of financial assets for the reporting period was ¥40,968,437, with a total of ¥5,916,557,389 purchased and ¥7,507,405,671 sold[92]. - The company's financial assets at the end of the period totaled ¥1,496,452,326, down from ¥3,043,437,737 at the beginning of the period[92]. - The company reported a loss of ¥23,575,910 from its investment in Shanghai Yifang during the reporting period[96]. - The company has established a stable production and supply system with production bases in multiple regions, enhancing management efficiency and reducing procurement costs[76]. Risk Management - The company faces various operational risks and has outlined corresponding measures in the report[5]. - The company is facing risks from macroeconomic fluctuations and has outlined measures to mitigate these risks[145][147]. - The company has adjusted its fundraising project plans, including terminating the "Huabao Lasa Healthy Food Project" and reallocating funds to the "Huabao Digital Transformation Project" and "Huabao Technology Innovation Center" projects[151]. - Raw material prices have experienced significant volatility due to international tensions and domestic pandemic outbreaks, prompting the company to optimize inventory management and reduce reliance on imported materials[155]. - The company is closely monitoring the impact of COVID-19 on operations and has implemented strict preventive measures to ensure employee safety and minimize operational disruptions[156]. Corporate Governance and Social Responsibility - The company has established a comprehensive environmental management system, including wastewater treatment facilities and air pollution control systems[171]. - The company actively engages in social responsibility, focusing on long-term development while ensuring shareholder and investor rights[172]. - The company emphasizes employee rights protection, fostering a fair and diverse work environment[176]. - The company maintains long-term cooperative relationships with suppliers and customers, adhering to principles of equality and mutual benefit[177]. - The company actively participates in social welfare activities, including donations for education and support for local farmers[179]. Commitments and Compliance - The company has committed to avoiding substantial competition with its subsidiaries and will not engage in competitive business activities through controlled enterprises[183]. - The commitment includes measures to resolve any potential competition, such as acquiring shares or assets of competing enterprises[183]. - The company guarantees not to provide proprietary technology or business secrets to competitors of its subsidiaries[183]. - The company will not occupy or transfer funds from its subsidiaries through any means[185]. - The commitments made by the controlling shareholders are valid until they remain in control of the company[183]. - The company is currently fulfilling all commitments made during its initial public offering and refinancing[183]. - There are no overdue commitments that have not been fulfilled as of the reporting period[188].